Weight loss injections like Ozempic® work by utilizing a medication called semaglutide, which is a GLP-1 receptor agonist. This type of medication helps regulate blood sugar levels and can also reduce appetite by affecting areas of the brain that control hunger. By reducing cravings and slowing down the rate at which food leaves the stomach, these injections help you eat less and feel fuller for longer, leading to weight loss over time. When combined with a healthy diet and regular exercise, Ozempic® and similar treatments can support significant weight loss.

Eligibility for prescription weight loss injections is determined by a licensed healthcare provider. Generally, these treatments are intended for adults with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity, such as type 2 diabetes, high blood pressure, or high cholesterol. It is not suitable for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

The timeline for results can vary depending on the individual, the specific medication, and lifestyle factors such as diet and exercise. Some users report feeling less hungry within the first few weeks of treatment. Significant weight loss is typically observed within the first 3 to 6 months of consistent use. It is important to have realistic expectations and to focus on long-term, sustainable progress.

Insurance coverage for weight loss injections varies widely. Some insurance plans may cover these medications, particularly if they are prescribed for the treatment of type 2 diabetes. However, coverage for weight loss alone is less common. Many of the telehealth companies we review offer cash-pay options and may provide assistance with insurance verification. We recommend contacting your insurance provider directly to understand your coverage.

Some of the most popular and effective weight loss injection brands include Wegovy® (semaglutide), Ozempic® (semaglutide), Mounjaro™ (tirzepatide), and Zepbound™ (tirzepatide). These medications have been shown in clinical trials to be effective for weight loss when combined with a reduced-calorie diet and increased physical activity.

Like all medications, GLP-1 receptor agonists can cause side effects. The most common side effects are gastrointestinal in nature and may include nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects are typically mild to moderate and tend to decrease over time as the body adjusts to the medication. It is important to discuss any side effects with your healthcare provider.